Annually, over 35,000 cases of oral and pharyngeal carcinoma are diagnosed in the United
States. Oral health care providers can be instrumental in reducing the incidence of oral and …

The right to health relevant information derives from the principles of autonomy and self
direction and has been recognised in international declarations. Providing accurate health …

Limited data are available on the carcinogenicity of smokeless tobacco products in organs
other than the mouth. Snus is a smokeless tobacco product widely used in Norway. We …

Background: Few prospective studies have examined the health risks associated with use of
snuff and chewing tobacco. Methods: We studied the association between the use of spit …

BACKGROUND: Cigarette manufacturers in the United States have begun marketing
cigarette brands claiming to reduce smokers' exposure to selected toxins in tobacco smoke …

The present study evaluated nicotine plasma levels achieved following 1 day's regular use
of four commonly used brands of Swedish portion snus and 2-mg Nicorette chewing gum …

Résumé Les carcinomes des voies aérodigestives supérieures (VADS) sont fréquents en
France chez les hommes. Ils regroupent les cancers de la cavité buccale, du pharynx et du …

Those who either never progress from smokeless tobacco (SLT) to smoking or smoked
before using SLT logically cannot have smoking caused by SLT use. The prevalence of such …

Objective: To estimate the number of deaths that could be prevented in the UK by
implementing population strategies to reduce smoking prevalence. Design: A prospective …

Tobacco harm reduction (THR) policies aim to reduce the prevalence of tobacco-related
harm by encouraging smokers who are unable or unwilling to quit to adopt less harmful …